BACKGROUND. The Cardiac Arrhythmia Suppression Trial (CAST) tested the hypothesis that the suppression of asymptomatic or mildly symptomatic ventricular premature depolarizations in survivors of myocardial infarction would decrease the number of deaths from ventricular arrhythmias and improve overall survival. The second CAST study (CAST-II) tested this hypothesis with a comparison of moricizine and placebo. METHODS. CAST-II was divided into two blinded, randomized phases: an early, 14-day exposure phase that evaluated the risk of starting treatment with moricizine after myocardial infarction (1325 patients), and a long-term phase that evaluated the effect of moricizine on survival after myocardial infarction in patients whose ventricular premature depolarizations were either adequately suppressed by moricizine (1155 patients) or only partially suppressed (219 patients). RESULTS. CAST-II was stopped early because the first 14-day period of treatment with moricizine after a myocardial infarction was associated with excess mortality (17 of 665 patients died or had cardiac arrests), as compared with no treatment or placebo (3 of 660 patients died or had cardiac arrests); and estimates of conditional power indicated that it was highly unlikely (less than 8 percent chance) that a survival benefit from moricizine could be observed if the trial were completed. At the completion of the long-term phase, there were 49 deaths or cardiac arrests due to arrhythmias in patients assigned to moricizine, and 42 in patients assigned to placebo (adjusted P = 0.40). CONCLUSIONS. As with the antiarrhythmic agents used in CAST-I (flecainide and encainide), the use of moricizine in CAST-II to suppress asymptomatic or mildly symptomatic ventricular premature depolarizations to try to reduce mortality after myocardial infarction is not only ineffective but also harmful.
This article has been cited by other articles:
Chang, M. G., Zhang, Y., Chang, C. Y., Xu, L., Emokpae, R., Tung, L., Marban, E., Abraham, M. R.
(2009). Spiral Waves and Reentry Dynamics in an In Vitro Model of the Healed Infarct Border Zone. Circ. Res.
105: 1062-1071
[Abstract][Full Text]
Fosbol, E. L., Gislason, G. H., Poulsen, H. E., Hansen, M. L., Folke, F., Schramm, T. K., Olesen, J. B., Bretler, D.-M., Abildstrom, S. Z., Sorensen, R., Hvelplund, A., Kober, L., Torp-Pedersen, C.
(2009). Prognosis in Heart Failure and the Value of {beta}-Blockers Are Altered by the Use of Antidepressants and Depend on the Type of Antidepressants Used. Circ Heart Fail
2: 582-590
[Abstract][Full Text]
Krishnamoorthy, S., Lip, G. Y.H.
(2009). How safe is the antiarrhythmic drug therapy in atrial fibrillation?. Europace
11: 837-839
[Full Text]
Gheorghiade, M., Pang, P. S.
(2009). Are BNP Changes During Hospitalization for Heart Failure a Reliable Surrogate for Predicting the Effects of Therapies on Post-Discharge Mortality?. J Am Coll Cardiol
53: 2349-2352
[Full Text]
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W.
(2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol
53: e1-e90
[Full Text]
Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W.
(2009). 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol
53: 1343-1382
[Full Text]
2009 WRITING GROUP TO REVIEW NEW EVIDENCE AND UPDA, , Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W.
(2009). 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation
119: 1977-2016
[Full Text]
2005 WRITING COMMITTEE MEMBERS, , Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W.
(2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation
119: e391-e479
[Full Text]
Bauer, A., Malik, M., Schmidt, G., Barthel, P., Bonnemeier, H., Cygankiewicz, I., Guzik, P., Lombardi, F., Muller, A., Oto, A., Schneider, R., Watanabe, M., Wichterle, D., Zareba, W.
(2008). Heart Rate Turbulence: Standards of Measurement, Physiological Interpretation, and Clinical Use: International Society for Holter and Noninvasive Electrophysiology Consensus. J Am Coll Cardiol
52: 1353-1365
[Abstract][Full Text]
Aliot, E., Ruskin, J. N.
(2008). Controversies in ablation of atrial fibrillation. Eur Heart J Suppl
10: H32-H54
[Abstract][Full Text]
Au, D. H
(2008). Use of {beta} blockers in patients with COPD. Thorax
63: 296-298
[Full Text]
Aydin, O., Becker, R., Kraft, P., Voss, F., Koch, M., Kelemen, K., Katus, H. A., Bauer, A.
(2007). Effects of protein kinase C activation on cardiac repolarization and arrhythmogenesis in Langendorff-perfused rabbit hearts. Europace
9: 1094-1098
[Abstract][Full Text]
Lujan, H. L., Kramer, V. J., DiCarlo, S. E.
(2007). Sex influences the susceptibility to reperfusion-induced sustained ventricular tachycardia and beta-adrenergic receptor blockade in conscious rats. Am. J. Physiol. Heart Circ. Physiol.
293: H2799-H2808
[Abstract][Full Text]
Scirica, B. M., Morrow, D. A., Hod, H., Murphy, S. A., Belardinelli, L., Hedgepeth, C. M., Molhoek, P., Verheugt, F. W.A., Gersh, B. J., McCabe, C. H., Braunwald, E.
(2007). Effect of Ranolazine, an Antianginal Agent With Novel Electrophysiological Properties, on the Incidence of Arrhythmias in Patients With Non ST-Segment Elevation Acute Coronary Syndrome: Results From the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) Randomized Controlled Trial. Circulation
116: 1647-1652
[Abstract][Full Text]
Hohnloser, S. H., Prystowsky, E. N.
(2007). CRT-D use in heart failure: too little or too much?. Eur Heart J Suppl
9: G9-G16
[Abstract][Full Text]
Finch, S. J., van Zyl, L. T.
(2006). Cardioversion of Persistent Atrial Arrhythmia After Treatment With Venlafaxine in Successful Management of Major Depression and Posttraumatic Stress Disorder. Psychosomatics
47: 533-536
[Abstract][Full Text]
Developed in Collaboration With the European Heart, , Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., Priori, S. G., Quinones, M. A., Roden, D. M., Silka, M. J., Tracy, C., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Antman, E. M., Anderson, J. L., Hunt, S. A., Halperin, J. L., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L.
(2006). ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol
48: e247-e346
[Full Text]
Writing Committee Members, , Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., Priori, S. G., Quinones, M. A., Roden, D. M., Silka, M. J., Tracy, C., ESC Committee for Practice Guidelines, , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L., ACC/AHA Task Force Members, , Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Antman, E. M., Anderson, J. L., Hunt, S. A., Halperin, J. L., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B.
(2006). ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace
8: 746-837
[Full Text]
Nash, M. P., Bradley, C. P., Sutton, P. M., Clayton, R. H., Kallis, P., Hayward, M. P., Paterson, D. J., Taggart, P.
(2006). Whole heart action potential duration restitution properties in cardiac patients: a combined clinical and modelling study. Exp Physiol
91: 339-354
[Abstract][Full Text]
Collette, L., Burzykowski, T., Carroll, K. J., Newling, D., Morris, T., Schroder, F. H.
(2005). Is Prostate-Specific Antigen a Valid Surrogate End Point for Survival in Hormonally Treated Patients With Metastatic Prostate Cancer? Joint Research of the European Organisation for Research and Treatment of Cancer, the Limburgs Universitair Centrum, and AstraZeneca Pharmaceuticals. JCO
23: 6139-6148
[Abstract][Full Text]
Macchia, A., Levantesi, G., Franzosi, M. G., Geraci, E., Maggioni, A. P., Marfisi, R., Nicolosi, G. L., Schweiger, C., Tavazzi, L., Tognoni, G., Valagussa, F., Marchioli, R., on behalf of the GISSI-Prevenzione Investigators,
(2005). Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids. Eur J Heart Fail
7: 904-909
[Abstract][Full Text]
Patwala, A Y, Wright, D J
(2005). Device based treatment of heart failure. Postgrad. Med. J.
81: 286-291
[Abstract][Full Text]
Roose, S. P., Miyazaki, M.
(2005). Pharmacologic Treatment of Depression in Patients With Heart Disease. Psychosom. Med.
67: S54-S57
[Abstract][Full Text]
Schulman, J. K., Muskin, P. R., Shapiro, P. A.
(2005). Psychiatry and Cardiovascular Disease. Focus
3: 208-224
[Abstract][Full Text]
DiDomenico, R. J., Massad, M. G.
(2005). Pharmacologic Strategies for Prevention of Atrial Fibrillation After Open Heart Surgery. Ann. Thorac. Surg.
79: 728-740
[Abstract][Full Text]
Roden, D. M.
(2005). An Underrecognized Challenge in Evaluating Postmarketing Drug Safety. Circulation
111: 246-248
[Full Text]
Shah, S U, Iqbal, Z, White, A, White, S
(2005). Heart and mind: (2) psychotropic and cardiovascular therapeutics. Postgrad. Med. J.
81: 33-40
[Abstract][Full Text]
Legro, R. S., Myers, E., for the Reproductive Medicine Network,
(2004). Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?. Hum Reprod
19: 1697-1704
[Abstract][Full Text]
de Groot, J. R, Coronel, R.
(2004). Acute ischemia-induced gap junctional uncoupling and arrhythmogenesis. Cardiovasc Res
62: 323-334
[Abstract][Full Text]
The AFFIRM Investigators,
(2004). Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation
109: 1509-1513
[Abstract][Full Text]
Prystowsky, E. N.
(2004). Primary Prevention of Sudden Cardiac Death: The Time of Your Life. Circulation
109: 1073-1075
[Full Text]
Yang, P., Kupershmidt, S., Roden, D. M.
(2004). Cloning and initial characterization of the human cardiac sodium channel (SCN5A) promoter. Cardiovasc Res
61: 56-65
[Abstract][Full Text]
Kasliwal, R. R, Mukesh, S., Manohar, G., Aggarwal, N., Bhatia, A.
(2003). Pharmacotherapy of Atrial Fibrillation. Asian Cardiovasc. Thorac. Ann.
11: 364-374
[Abstract][Full Text]
O'Brien, P., Oyebode, F.
(2003). Psychotropic medication and the heart. Adv. Psychiatr. Treat.
9: 414-423
[Abstract][Full Text]
Kaptchuk, T. J
(2003). Effect of interpretive bias on research evidence. BMJ
326: 1453-1455
[Full Text]
Zipes, D. P.
(2003). Less Heart Is More. Circulation
107: 2531-2532
[Full Text]
lost, N., Virag, L., Varro, A., Papp, J. Gy.
(2003). Comparison of the Effect of Class IA Antiarrhythmic Drugs on Transmembrane Potassium Currents in Rabbit Ventricular Myocytes. J CARDIOVASC PHARMACOL THER
8: 31-41
[Abstract]
Wong, C-K, White, H D, Wilcox, R G, Criger, D A, Califf, R M, Topol, E J, Ohman, E M
(2002). Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Heart
88: 357-362
[Abstract][Full Text]
DeMets, D. L., Califf, R. M.
(2002). Lessons Learned From Recent Cardiovascular Clinical Trials: Part I. Circulation
106: 746-751
[Full Text]
Dias Da Silva, V. J., Gnecchi-Ruscone, T., Lavelli, B., Bellina, V., Manzella, D., Porta, A., Malliani, A., Montano, N.
(2002). Opposite effects of iv amiodarone on cardiovascular vagal and sympathetic efferent activities in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol.
283: R543-R548
[Abstract][Full Text]
Temple, R. J., Himmel, M. H.
(2002). Safety of Newly Approved Drugs: Implications for Prescribing. JAMA
287: 2273-2275
[Full Text]
Holloway, R. G., Dick, A. W.
(2002). Clinical trial end points: On the road to nowhere?. Neurology
58: 679-686
[Abstract][Full Text]
Ansakorpi, H, Korpelainen, J T, Huikuri, H V, Tolonen, U, Myllyla, V V, Isojarvi, J I T
(2002). Heart rate dynamics in refractory and well controlled temporal lobe epilepsy. J. Neurol. Neurosurg. Psychiatry
72: 26-30
[Abstract][Full Text]
Maisel, W. H., Rawn, J. D., Stevenson, W. G.
(2001). Atrial Fibrillation after Cardiac Surgery. ANN INTERN MED
135: 1061-1073
[Abstract][Full Text]
Klingenheben, T., Gronefeld, G., Li, Y.-G., Hohnloser, S. H.
(2001). Effect of metoprolol and d,l-sotalol on microvolt-level T-wave alternans: Results of a prospective, double-blind, randomized study. J Am Coll Cardiol
38: 2013-2019
[Abstract][Full Text]
Nelson, L. A., Abu-Shanab, J. R.
(2001). Management of Depression in Patients with Comorbid Cardiovascular Disease. Journal of Pharmacy Practice
14: 526-539
[Abstract]
Hennessy, M. J., Tighe, M. G., Binnie, C. D., Nashef, L.
(2001). Sudden withdrawal of carbamazepine increases cardiac sympathetic activity in sleep. Neurology
57: 1650-1654
[Abstract][Full Text]
Ziegelstein, R. C.
(2001). Depression in Patients Recovering From a Myocardial Infarction. JAMA
286: 1621-1627
[Abstract][Full Text]
Priori, S.G., Aliot, E., Blomstrom-Lundqvist, C., Bossaert, L., Breithardt, G., Brugada, P., Camm, A.J., Cappato, R., Cobbe, S.M., Di Mario, C., Maron, B.J., McKenna, W.J., Pedersen, A.K., Ravens, U., Schwartz, P.J., Trusz-Gluza, M., Vardas, P., Wellens, H.J.J., Zipes, D.P.
(2001). Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J
22: 1374-1450
Schmitt, C., Barthel, P., Ndrepepa, G., Schreieck, J.u., Plewan, A., Schomig, A., Schmidt, G.
(2001). Value of programmed ventricular stimulation for prophylactic internal cardioverter-defibrillator implantation in postinfarction patients preselected by noninvasive risk stratifiers. J Am Coll Cardiol
37: 1901-1907
[Abstract][Full Text]
Singh, B. N., Sarma, J. S. M.
(2001). Mechanisms of Action of Antiarrhythmic Drugs Relative to the Origin and Perpetuation of Cardiac Arrhythmias. J CARDIOVASC PHARMACOL THER
6: 69-87
Camm, A. J., Yap, Y. G.
(2001). Clinical Trials of Antiarrhythmic Drugs in Postmyocardial Infarction and Congestive Heart Failure Patients. J CARDIOVASC PHARMACOL THER
6: 99-106
Raatikainen, M. J. P., Morey, T. E., Druzgala, P., Milner, P., Gonzalez, M. D., Dennis, D. M.
(2000). Potent and Reversible Effects of ATI-2001 on Atrial and Atrioventricular Nodal Electrophysiological Properties in Guinea Pig Isolated Perfused Heart. J. Pharmacol. Exp. Ther.
295: 779-785
[Abstract][Full Text]
Nademanee, K., Taylor, R., Bailey, W. E., Rieders, D. E., Kosar, E. M.
(2000). Treating Electrical Storm : Sympathetic Blockade Versus Advanced Cardiac Life Support-Guided Therapy. Circulation
102: 742-747
[Abstract][Full Text]
Kuck, K.-H., Cappato, R., Siebels, J., Ruppel, R.
(2000). Randomized Comparison of Antiarrhythmic Drug Therapy With Implantable Defibrillators in Patients Resuscitated From Cardiac Arrest : The Cardiac Arrest Study Hamburg (CASH). Circulation
102: 748-754
[Abstract][Full Text]
Willenheimer, R, Dahlof, B, Gordon, A
(2000). Clinical trials in cardiovascular medicine: are we looking for statistical significance or clinical relevance?. Heart
84: 129-133
[Full Text]
Hancox, J C, Patel, K C R, Jones, J V
(2000). Antiarrhythmics---from cell to clinic: past, present, and future. Heart
84: 14-24
[Full Text]
Knollmann, B. C, Knollmann-Ritschel, B. E C, Weissman, N. J, Jones, L. R, Morad, M.
(2000). Remodelling of ionic currents in hypertrophied and failing hearts of transgenic mice overexpressing calsequestrin. J. Physiol.
525: 483-498
[Abstract][Full Text]
Kelloff, G. J., Sigman, C. C., Johnson, K. M., Boone, C. W., Greenwald, P., Crowell, J. A., Hawk, E. T., Doody, L. A.
(2000). Perspectives on Surrogate End Points in the Development of Drugs that Reduce the Risk of Cancer. Cancer Epidemiol. Biomarkers Prev.
9: 127-137
[Abstract][Full Text]
Pratt, C.M, Camm, A.J, Bigger, J.T Jr, Breithardt, G, Campbell, R.W.F, Epstein, A.E, Kappenberger, L.J, Kuck, K.-H, Pocock, S, Saksena, S, Waldo, A.L
(1999). Evaluation of antiarrhythmic drug efficacy in patients with an ICD. Unlimited potential or replete with complexity and problems?. Eur Heart J
20: 1538-1552
[Abstract]
Crawford, M. H., Bernstein, S. J., Deedwania, P. C., DiMarco, J. P., Ferrick, K. J., Garson, A. Jr, Green, L. A., Greene, H. L., Silka, M. J., Stone, P. H., Tracy, C. M., Gibbons, R. J., Alpert, J. S., Eagle, K. A., Gardner, T. J., Garson, A. Jr, Gregoratos, G., Russell, R. O., Ryan, T. J., Smith, S. C. Jr
(1999). ACC/AHA guidelines for ambulatory electrocardiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography) developed in collaboration with the North American Society for Pacing and Electrophysiology. J Am Coll Cardiol
34: 912-948
[Full Text]
Temple, R.
(1999). Are Surrogate Markers Adequate to Assess Cardiovascular Disease Drugs?. JAMA
282: 790-795
[Full Text]
Guyatt, G.
(1999). A 75-Year-Old Man With Congestive Heart Failure. JAMA
281: 2321-2328
[Full Text]
Kaye, D. M., Dart, A. M., Jennings, G. L., Esler, M. D.
(1999). Antiadrenergic effect of chronic amiodarone therapy in human heart failure. J Am Coll Cardiol
33: 1553-1559
[Abstract][Full Text]
Cannom, D. S., Prystowsky, E. N.
(1999). Management of Ventricular Arrhythmias: Detection, Drugs, and Devices. JAMA
281: 172-179
[Abstract][Full Text]
Kuhlkamp, V., Mewis, C., Mermi, J., Bosch, R. F., Seipel, L.
(1999). Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment. J Am Coll Cardiol
33: 46-52
[Abstract][Full Text]
Singh, B. N.
(1999). Review : Sotalol: Current Status and Expanding Indications. J CARDIOVASC PHARMACOL THER
4: 49-65
[Abstract]
Valderrabano, M., Singh, B. N.
(1999). Review : Electrophysiologic and Antiarrhythmic Effects of Propafenone: Focus on Atrial Fibrillation. J CARDIOVASC PHARMACOL THER
4: 183-198
Zipes, D. P., Wellens, H. J. J.
(1998). Sudden Cardiac Death. Circulation
98: 2334-2351
[Full Text]
Singh, S. N., Fisher, S. G., Carson, P. E., Fletcher, R. D., the Department of Veterans Affairs CHF STAT Invest,
(1998). Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy. J Am Coll Cardiol
32: 942-947
[Abstract][Full Text]
Chung, M. K., Schweikert, R. A., Wilkoff, B. L., Niebauer, M. J., Pinski, S. L., Trohman, R. G., Kidwell, G. A., Jaeger, F. J., Morant, V. A., Miller, D. P., Tchou, P. J.
(1998). Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required?: yield of in-hospital monitoring and prediction of risk for significant arrhythmia complications. J Am Coll Cardiol
32: 169-176
[Abstract][Full Text]
Kirchhof, P. F., Fabritz, C. L., Franz, M. R.
(1998). Postrepolarization Refractoriness Versus Conduction Slowing Caused by Class I Antiarrhythmic Drugs : Antiarrhythmic and Proarrhythmic Effects. Circulation
97: 2567-2574
[Abstract][Full Text]
Roose, S. P., Glassman, A. H., Attia, E., Woodring, S., Giardina, E.-G. V., Bigger, J. T. Jr.
(1998). Cardiovascular Effects of Fluoxetine in Depressed Patients With Heart Disease. Am. J. Psychiatry
155: 660-665
[Abstract][Full Text]
Bosch, R. F., Gaspo, R., Busch, A. E., Lang, H. J., Li, G.-R., Nattel, S.
(1998). Effects of the chromanol 293B, a selective blocker of the slow, component of the delayed rectifier K+ current, on repolarization in human and guinea pig ventricular myocytes. Cardiovasc Res
38: 441-450
[Abstract][Full Text]
Myerburg, R. J., Mitrani, R., Interian, A. Jr, Castellanos, A.
(1998). Interpretation of Outcomes of Antiarrhythmic Clinical Trials : Design Features and Population Impact. Circulation
97: 1514-1521
[Full Text]
Siogas, K, Pappas, S, Graekas, G, Goudevenos, J, Liapi, G, Sideris, D A
(1998). Segmental wall motion abnormalities alter vulnerability to ventricular ectopic beats associated with acute increases in aortic pressure in patients with underlying coronary artery disease. Heart
79: 268-273
[Abstract][Full Text]
Nattel, S.
(1998). Experimental evidence for proarrhythmic mechanisms of antiarrhythmic drugs. Cardiovasc Res
37: 567-577
[Abstract][Full Text]
Roose, S. P., Laghrissi-Thode, F., Kennedy, J. S., Nelson, J. C., Bigger, J. T. Jr, Pollock, B. G., Gaffney, A., Narayan, M., Finkel, M. S., McCafferty, J., Gergel, I.
(1998). Comparison of Paroxetine and Nortriptyline in Depressed Patients With Ischemic Heart Disease. JAMA
279: 287-291
[Abstract][Full Text]
Gheorghiade, M., Bonow, R. O.
(1998). Chronic Heart Failure in the United States : A Manifestation of Coronary Artery Disease. Circulation
97: 282-289
[Full Text]
Colatsky, T. J.
(1998). Controlling Cardiac Arrhythmias: New Drugs in Development and Insights From Molecular Biology. J CARDIOVASC PHARMACOL THER
3: 337-341
Goldstein, B. J., Goodnick, P. J
(1998). Selective serotonin reuptake inhibitors in the treatment of affective disorders--III. Tolerability, safety and pharmacoeconomics. J Psychopharmacol
12: 55-S87
[Abstract]
Trappe, H.-J., Pfitzner, P., Achtelik, M., Fieguth, H.-G.
(1997). Age dependent efficacy of implantable cardioverter-defibrillator treatment: observations in 450 patients over an 11 year period. Heart
78: 364-370
[Abstract][Full Text]
Domanski, M. J., Zipes, D. P., Schron, E.
(1997). Treatment of Sudden Cardiac Death : Current Understandings From Randomized Trials and Future Research Directions. Circulation
95: 2694-2699
[Full Text]
Topol, E. J., Califf, R. M., Van de Werf, F., Simoons, M., Hampton, J., Lee, K. L., White, H., Simes, J., Armstrong, P. W.
(1997). Perspectives on Large-Scale Cardiovascular Clinical Trials for the New Millennium. Circulation
95: 1072-1082
[Full Text]
Epstein, A. E.
(1997). MADIT Does Not Provide the Basis for Developing Therapeutic Strategy for Patients With Severely Depressed Ventricular Ejection Fraction With Nonsustained Ventricular Tachycardia. J CARDIOVASC PHARMACOL THER
2: 234-237
Singh, B. N.
(1997). Searching for the Ideal Class III Antiarrhythmic Agent: How Pure Should They Be?. J CARDIOVASC PHARMACOL THER
2: 239-242
Nemeth, M., Varro, A., Virag, L., Hala, O., Thormahlen, D., Gyula Papp, J.
(1997). Frequency-dependent Cardiac Electrophysiologic Effects of Tedisamil: Comparison With Quinidine and Sotalol. J CARDIOVASC PHARMACOL THER
2: 273-284
[Abstract]
Friedman, P. L., Stevenson, W. G.
(1996). Unsustained Ventricular Tachycardia -- To Treat or Not to Treat. NEJM
335: 1984-1985
[Full Text]
Hennekens, C. H., Albert, C. M., Godfried, S. L., Gaziano, J. M., Buring, J. E.
(1996). Adjunctive Drug Therapy of Acute Myocardial Infarction -- Evidence from Clinical Trials. NEJM
335: 1660-1668
[Full Text]
Friedrichs, G.S., Abreu, J.N., Cousins, G.R., Chi, L., Borlak, J., Lucchesi, B.R.
(1996). Tedisamil Attenuates Ventricular Fibrillation in a Conscious Canine Model of Sudden Cardiac Death. J CARDIOVASC PHARMACOL THER
1: 313-324
[Abstract]
Goldstein, S.
(1996). {beta}-Blockers in Hypertensive and Coronary Heart Disease. Arch Intern Med
156: 1267-1276
[Abstract]
Singh, B. N.
(1996). Editorial: Rise and Fall of Guided Antiarrhythmic Therapy for Ventricular Tachycardia and Fibrillation. J CARDIOVASC PHARMACOL THER
1: 89-94
Pratt, C. M., Greenway, P. S., Schoenfeld, M. H., Hibben, M. L., Reiffel, J. A.
(1996). Exploration of the Precision of Classifying Sudden Cardiac Death : Implications for the Interpretation of Clinical Trials. Circulation
93: 519-524
[Abstract][Full Text]
Singh, B. N.
(1996). Antiarrhythmic Therapy of Ventricular Arrhythmias: The Contemporary Dilemma. J CARDIOVASC PHARMACOL THER
1: 3-7
Nademanee, K., Noll, H. E., Feld, G. K.
(1996). Effects of Sotalol on His-Purkinje Conduction and Refractoriness in Humans. J CARDIOVASC PHARMACOL THER
1: 9-16
[Abstract]
Sheldon, R., Duff, H., Koshman, M. L.
(1995). Antiarrhythmic Activity of Quinine in Humans. Circulation
92: 2944-2950
[Abstract][Full Text]
Previous
